share_log

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

Morgan Stanley Upgrades Centessa Pharmaceuticals to Equal-Weight, Raises Price Target to $8

摩根士丹利将Centessa Pharmicals上调至同等权重,将目标股价提高至8美元
Benzinga ·  2023/10/26 05:07

Morgan Stanley analyst Matthew Harrison upgrades Centessa Pharmaceuticals (NASDAQ:CNTA) from Underweight to Equal-Weight and raises the price target from $4 to $8.

摩根士丹利分析师马修·哈里森将Centessa PharmPharmticals(纳斯达克股票代码:CNTA)的评级从减持上调至持平,并将目标价从4美元上调至8美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发